Delivery Order SPE2DB20D2001-SPE2DB25FPNTY
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 14, 2025, for the supply of Trintellix 10 mg tablets in a quantity of 30 units, with a contract ceiling value of $2,193.73 and an ultimate completion date of December 15, 2025. This non-set-aside delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement needs, with performance to be fulfilled at the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Trintellix 5 mg tablets (30-count) with a contract ceiling value of $4,978.44. This firm fixed-price delivery order represents a non-set-aside competitive award and is scheduled for completion by August 5, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Trintellix 5 mg tablets (30-count packages) with a contract value of $1,479.86. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The order is due for completion by November 7, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $2,491.15 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Trintellix 20 mg tablets in a quantity of 30 units. This non-set-aside, competitively awarded contract features firm fixed price pricing with an ultimate completion date of September 19, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,955.35 on August 4, 2025, for the supply of Trintellix 20 mg tablets (30-count packages). This is a firm fixed-price, non-set-aside contract with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of August 5, 2025. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion...
- The Defense Logistics Agency awarded a delivery order valued at $31,723.92 to AmerisourceBergen Drug Corp for the supply of Trintellix 5 mg tablets (30-count units) on September 25, 2025, with completion scheduled for September 26, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award status. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Trintellix 10 mg tablets (30-count) under a firm fixed-price contract valued at $4,781.16. This is a non-set-aside competitive award with an ultimate completion date of August 21, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $1,544.96 for Trintellix 5 mg tablets (30-count) by the Medical Supply Chain, a Defense agency component. The contract was awarded on September 16, 2025, with an ultimate completion date of September 17, 2025, and utilizes firm fixed price pricing with no set-aside designation. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 25, 2025, for Trintellix 20 mg tablets (quantity: 30-count packages) with a ceiling value of $2,085.44. This contract is a firm fixed-price delivery order issued under a non-competitive set-aside and carries an ultimate completion date of September 26, 2025. The place of performance is located at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,016.30 to AmerisourceBergen Drug Corp for the supply of Trintellix 5 mg tablets (30-count) on September 23, 2025, with completion scheduled for September 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB25FPNTYDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Trintellix 20 mg tablets (30-count) with a ceiling value of $5,763.62. This non-set-aside contract utilizes firm fixed pricing and is scheduled for ultimate completion by September 23, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and is fulfilling this order from its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. This arrangement allows AmerisourceBergen to efficiently fulfill pharmaceutical requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through a flexible contracting mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 9/22/25 |